Cargando…

Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia characterized by syncope and sudden death occurring during exercise or acute emotion. CPVT is caused by abnormal intracellular Ca(2+) handling resulting from mutations in the RyR2 or CASQ2 genes. Because CASQ2 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Atara, Barad, Lili, Lorber, Avraham, Gherghiceanu, Mihaela, Reiter, Irina, Eisen, Binyamin, Eldor, Liron, Itskovitz-Eldor, Joseph, Eldar, Michael, Arad, Michael, Binah, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549051/
https://www.ncbi.nlm.nih.gov/pubmed/26153920
http://dx.doi.org/10.1111/jcmm.12581
_version_ 1782387259723481088
author Novak, Atara
Barad, Lili
Lorber, Avraham
Gherghiceanu, Mihaela
Reiter, Irina
Eisen, Binyamin
Eldor, Liron
Itskovitz-Eldor, Joseph
Eldar, Michael
Arad, Michael
Binah, Ofer
author_facet Novak, Atara
Barad, Lili
Lorber, Avraham
Gherghiceanu, Mihaela
Reiter, Irina
Eisen, Binyamin
Eldor, Liron
Itskovitz-Eldor, Joseph
Eldar, Michael
Arad, Michael
Binah, Ofer
author_sort Novak, Atara
collection PubMed
description Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia characterized by syncope and sudden death occurring during exercise or acute emotion. CPVT is caused by abnormal intracellular Ca(2+) handling resulting from mutations in the RyR2 or CASQ2 genes. Because CASQ2 and RyR2 are involved in different aspects of the excitation-contraction coupling process, we hypothesized that these mutations are associated with different functional and intracellular Ca²(+) abnormalities. To test the hypothesis we generated induced Pluripotent Stem Cell-derived cardiomyocytes (iPSC-CM) from CPVT1 and CPVT2 patients carrying the RyR2(R420Q) and CASQ2(D307H) mutations, respectively, and investigated in CPVT1 and CPVT2 iPSC-CM (compared to control): (i) The ultrastructural features; (ii) the effects of isoproterenol, caffeine and ryanodine on the [Ca(2+)](i) transient characteristics. Our major findings were: (i) Ultrastructurally, CASQ2 and RyR2 mutated cardiomyocytes were less developed than control cardiomyocytes. (ii) While in control iPSC-CM isoproterenol caused positive inotropic and lusitropic effects, in the mutated cardiomyocytes isoproterenol was either ineffective, caused arrhythmias, or markedly increased diastolic [Ca(2+)](i). Importantly, positive inotropic and lusitropic effects were not induced in mutated cardiomyocytes. (iii) The effects of caffeine and ryanodine in mutated cardiomyocytes differed from control cardiomyocytes. Our results show that iPSC-CM are useful for investigating the similarities/differences in the pathophysiological consequences of RyR2 versus CASQ2 mutations underlying CPVT1 and CPVT2 syndromes.
format Online
Article
Text
id pubmed-4549051
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45490512015-08-28 Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations Novak, Atara Barad, Lili Lorber, Avraham Gherghiceanu, Mihaela Reiter, Irina Eisen, Binyamin Eldor, Liron Itskovitz-Eldor, Joseph Eldar, Michael Arad, Michael Binah, Ofer J Cell Mol Med Original Articles Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia characterized by syncope and sudden death occurring during exercise or acute emotion. CPVT is caused by abnormal intracellular Ca(2+) handling resulting from mutations in the RyR2 or CASQ2 genes. Because CASQ2 and RyR2 are involved in different aspects of the excitation-contraction coupling process, we hypothesized that these mutations are associated with different functional and intracellular Ca²(+) abnormalities. To test the hypothesis we generated induced Pluripotent Stem Cell-derived cardiomyocytes (iPSC-CM) from CPVT1 and CPVT2 patients carrying the RyR2(R420Q) and CASQ2(D307H) mutations, respectively, and investigated in CPVT1 and CPVT2 iPSC-CM (compared to control): (i) The ultrastructural features; (ii) the effects of isoproterenol, caffeine and ryanodine on the [Ca(2+)](i) transient characteristics. Our major findings were: (i) Ultrastructurally, CASQ2 and RyR2 mutated cardiomyocytes were less developed than control cardiomyocytes. (ii) While in control iPSC-CM isoproterenol caused positive inotropic and lusitropic effects, in the mutated cardiomyocytes isoproterenol was either ineffective, caused arrhythmias, or markedly increased diastolic [Ca(2+)](i). Importantly, positive inotropic and lusitropic effects were not induced in mutated cardiomyocytes. (iii) The effects of caffeine and ryanodine in mutated cardiomyocytes differed from control cardiomyocytes. Our results show that iPSC-CM are useful for investigating the similarities/differences in the pathophysiological consequences of RyR2 versus CASQ2 mutations underlying CPVT1 and CPVT2 syndromes. John Wiley & Sons, Ltd 2015-08 2015-07-08 /pmc/articles/PMC4549051/ /pubmed/26153920 http://dx.doi.org/10.1111/jcmm.12581 Text en © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Novak, Atara
Barad, Lili
Lorber, Avraham
Gherghiceanu, Mihaela
Reiter, Irina
Eisen, Binyamin
Eldor, Liron
Itskovitz-Eldor, Joseph
Eldar, Michael
Arad, Michael
Binah, Ofer
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
title Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
title_full Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
title_fullStr Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
title_full_unstemmed Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
title_short Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
title_sort functional abnormalities in ipsc-derived cardiomyocytes generated from cpvt1 and cpvt2 patients carrying ryanodine or calsequestrin mutations
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549051/
https://www.ncbi.nlm.nih.gov/pubmed/26153920
http://dx.doi.org/10.1111/jcmm.12581
work_keys_str_mv AT novakatara functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT baradlili functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT lorberavraham functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT gherghiceanumihaela functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT reiteririna functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT eisenbinyamin functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT eldorliron functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT itskovitzeldorjoseph functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT eldarmichael functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT aradmichael functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations
AT binahofer functionalabnormalitiesinipscderivedcardiomyocytesgeneratedfromcpvt1andcpvt2patientscarryingryanodineorcalsequestrinmutations